Private Placement Financings

Executive Summary

SJA exceeds client financing objectives by leveraging the company’s extensive network of institutional, angel group syndicates, and alternative investors (accredited, family offices) to finance early to mid-stage biotech companies through major value inflection points / milestones.

Effective at negotiating and closing Series / convertible preferred rounds with institutional capital sources (venture capital, cross-over) and identifying / gaining commitment from Lead Investors pivotal to attracting syndicates.